NasdaqGS - Delayed Quote USD

Sinovac Biotech Ltd. (SVA)

6.47 0.00 (0.00%)
At close: April 4 at 4:00 PM EDT

Key Executives

Sinovac Biotech Ltd.

Description

Corporate Governance

Sinovac Biotech Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Feb 21, 2024
    8-A12B/A: Trading Registrations
    See Full Filing
  • Jan 18, 2024
    SC 14D9: Tender Offer/Acquisition Reports
    See Full Filing
  • Dec 04, 2023
    SC 13D/A: Tender Offer/Acquisition Reports
    See Full Filing
  • Oct 05, 2023
    CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
    See Full Filing
  • Sep 15, 2023
    SC 13D/A: Tender Offer/Acquisition Reports
    See Full Filing

Upcoming Events

Related Tickers

HSTC HST Global, Inc.
0.6500
0.00%
 
688136.SS Kexing Biopharm Co., Ltd.
15.17
+2.15%
 
YECO EV Biologics, Inc.
0.6021
0.00%
 
LIPO Lipella Pharmaceuticals Inc.
0.7128
+1.25%
 
XCUR Exicure, Inc.
0.5150
-4.68%
 
FBRX Forte Biosciences, Inc.
0.7199
-2.53%
 
NBSE NeuBase Therapeutics, Inc.
0.4210
0.00%
 
DBVT DBV Technologies S.A.
0.6910
-2.06%
 
ORGS Orgenesis Inc.
0.5020
-3.28%
 
SLRX Salarius Pharmaceuticals, Inc.
0.5080
+1.40%